Cargando…
Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome
Through both gain- and loss-of-TTF-1 expression strategies, we show that TTF-1 positively regulates vascular endothelial growth factor (VEGF) and that the VEGF promoter element contains multiple TTF-1-responsive sequences. The major signaling receptor for VEGF, i.e VEGFR2, also appears to be under a...
Autores principales: | Wood, Lauren W., Cox, Nicole I., Phelps, Cody A., Lai, Shao-Chiang, Poddar, Arjun, Talbot, Conover, Mu, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766481/ https://www.ncbi.nlm.nih.gov/pubmed/26912193 http://dx.doi.org/10.1038/srep19857 |
Ejemplares similares
-
Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism
por: Lai, Shao-Chiang, et al.
Publicado: (2018) -
The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts
por: Dore-Savard, Louis, et al.
Publicado: (2016) -
Effect of Hypoxia Preconditioned Secretomes on Lymphangiogenic and Angiogenic Sprouting: An in Vitro Analysis
por: Moog, Philipp, et al.
Publicado: (2020) -
Clinical potential of angiogenic therapy and cellular reprogramming
por: Ryan, Christopher T., et al.
Publicado: (2021) -
Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties
por: Ribot, Jonathan, et al.
Publicado: (2016)